Company Overview
CYTOMX THERAPEUTICS, INC.
CTMXRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
76M
2025 FY
Net Income
-17M
2025 FY
Shares Outstanding
138M
2025 FY
EPS
USD
2025 FY
Company Information
SIC Code
2834
CIK Code
1501989
Exchange
Nasdaq
Location
US